SCHEMBL14568139

SCHEMBL14568139

Bc1cncc(C(O)c2ccccc2)c1O

nearest known ligand 0.44

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 1/20 0.44
▸ CYP11B1 P15538 1/20 0.40
▸ CYP11B2 P19099 1/20 0.40
▸ GAA P10253 1/20 0.38
▸ MEN1 O00255 1/20 0.37
▸ MAPT P10636 1/20 0.37
▸ CYP2C9 P11712 1/20 0.37
▸ KMT2A Q03164 1/20 0.37
▸ CYP17A1 P05093 1/20 0.35
▸ ADORA2A P29274 2/20 0.35
▸ ADORA1 P30542 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.34
▸ LMNA P02545 2/20 0.33
▸ IDO1 P14902 1/20 0.33
▸ TDO2 P48775 1/20 0.33
▸ HPGD P15428 2/20 0.33
▸ KDM4E B2RXH2 1/20 0.33
▸ L3MBTL1 Q9Y468 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1137096 0.79 SMN1; SMN2 (0.49) SMN1; SMN2CYP11B1CYP11B2GAAMEN1
SCHEMBL7809671 0.68 MEN1 (0.63) SMN1; SMN2GAAMEN1MAPTCYP2C9
SCHEMBL9846980 0.67 SMN1; SMN2 (0.55) SMN1; SMN2CYP11B1CYP11B2GAAMEN1
SCHEMBL8017634 0.67 SMN1; SMN2 (0.55) SMN1; SMN2CYP11B1CYP11B2GAAMEN1
SCHEMBL3064009 0.67 SMN1; SMN2 (0.55) SMN1; SMN2CYP11B1CYP11B2GAAMEN1
SCHEMBL30034215 0.67 SMN1; SMN2 (0.55) SMN1; SMN2CYP11B1CYP11B2GAAMEN1
SCHEMBL5135302 0.66 SMN1; SMN2 (0.49) SMN1; SMN2CYP11B1CYP11B2GAAMAPT
SCHEMBL29405346 0.65 MAPT (0.50) SMN1; SMN2MEN1MAPTCYP2C9KMT2A
SCHEMBL984999 0.65 MAPT (0.50) SMN1; SMN2MEN1MAPTCYP2C9KMT2A
Diphenylmethanol SCHEMBL11564700 0.65 SMN1; SMN2 (0.61) SMN1; SMN2LMNAKDM4EL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007033196-A1 MET KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2007-03-22 — — WO disclosed
Send feedback